1. Adapted from Mundt JC, Freed DM. Lay person-based screening for early

The Prevagen Memory Study was an open-label study for 56 participants over a 30 day

period. Changes in performance were measured via a memory screening tool1. The study

showed improved memory performance as early as eight days but with statistically greater

improvement at day 30*. No participants discontinued the study due to an adverse event.

Many cellular processes are closely regulated under normal functioning. Calcium-binding

proteins regulate calcium to keep a balance within the nervous system. Aging reduces an

individual’s production of calcium-binding proteins. As the levels of calcium-binding

proteins decline, calcium is not as regulated, leaving brain cells vulnerable. Excess calcium

can result in cell damage and memory impairment. Fortunately, Prevagen provides a supplemental

source of calcium-binding proteins to protect the cells, helping restore calcium

balance*.

*These statements have not been evaluated by the Food and Drug Administration.

This product is not intended to diagnose, treat, cure or prevent any disease.

Patent Pending.

2008 PREVAGEN MEMORY STUDY, QUINCY BIOSCIENCE

Word

Recall

Remembering

Driving

Directions

Retaining

Information

90%

80%

70%

60%

50%

40%

30%

20%

10%

31% 27%

52%

General

Memory